Use of intravitreal rituximab for treatment of vitreoretinal lymphoma

Abstract

Approaches in rituximab-based intravitreal chemotherapy vary widely, but our findings suggest that this treatment may be safe and effective in inducing remission in a majority of eyes with vitreoretinal lymphoma.